aspirin has been researched along with Achalasia in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient was diagnosed with type I achalasia." | 5.62 | Esophageal achalasia with mucosal damage due to enteric-coated aspirin. ( Akitaya, K; Chinda, D; Fukuda, S; Hasui, K; Hiraga, H; Igarashi, S; Kikuchi, H; Mikami, T; Sakuraba, H; Sawaya, M; Shimoyama, T; Suto, S; Tatsuta, T, 2021) |
| "Our data suggests that lymphocytic esophagitis is more likely to be found in older female patients and is significantly associated with achalasia, statin, and aspirin use." | 4.02 | Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes. ( Bi, Y; Brahmbhatt, B; DeVault, KR; Ghoz, H; Krishna, M; Lacy, BE; Malviya, BJ; Palmer, WC; Zaver, HB, 2021) |
| "The patient was diagnosed with type I achalasia." | 1.62 | Esophageal achalasia with mucosal damage due to enteric-coated aspirin. ( Akitaya, K; Chinda, D; Fukuda, S; Hasui, K; Hiraga, H; Igarashi, S; Kikuchi, H; Mikami, T; Sakuraba, H; Sawaya, M; Shimoyama, T; Suto, S; Tatsuta, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaver, HB | 1 |
| Ghoz, H | 1 |
| Malviya, BJ | 1 |
| Brahmbhatt, B | 1 |
| Palmer, WC | 1 |
| Lacy, BE | 1 |
| DeVault, KR | 1 |
| Krishna, M | 1 |
| Bi, Y | 1 |
| Tatsuta, T | 1 |
| Chinda, D | 1 |
| Mikami, T | 1 |
| Suto, S | 1 |
| Akitaya, K | 1 |
| Igarashi, S | 1 |
| Hasui, K | 1 |
| Kikuchi, H | 1 |
| Hiraga, H | 1 |
| Sawaya, M | 1 |
| Sakuraba, H | 1 |
| Shimoyama, T | 1 |
| Fukuda, S | 1 |
| Benech, N | 1 |
| Pioche, M | 1 |
| O'Brien, M | 1 |
| Rivory, J | 1 |
| Roman, S | 1 |
| Mion, F | 1 |
| Ponchon, T | 1 |
| RESANO, CH | 1 |
| LIZARRAGA, AA | 1 |
4 other studies available for aspirin and Achalasia
| Article | Year |
|---|---|
Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes.
Topics: Aged; Aspirin; Biopsy; Eosinophilic Esophagitis; Esophageal Achalasia; Esophagitis; Euterpe; Female; | 2021 |
Esophageal achalasia with mucosal damage due to enteric-coated aspirin.
Topics: Aged; Aspirin; Deglutition Disorders; Endoscopy, Digestive System; Esophageal Achalasia; Humans; Mal | 2021 |
Esophageal hematoma after peroral endoscopic myotomy for achalasia in a patient on antiplatelet therapy.
Topics: Aspirin; Esophageal Achalasia; Esophageal Sphincter, Lower; Esophagoscopy; Female; Hematoma; Humans; | 2015 |
[MEGAESOPHAGUS AND DRUG-INDUCED HEMORRHAGE].
Topics: Aspirin; Cortisone; Esophageal Achalasia; Esophagus; Geriatrics; Hemorrhage; Toxicology | 1964 |